Haleon PLC Sponsored ADR (NYSE:HLN) Receives Average Recommendation of “Moderate Buy” from Analysts

Haleon PLC Sponsored ADR (NYSE:HLN) has earned a consensus recommendation of “Moderate Buy” from the eleven analysts that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, three have assigned a buy rating and two have issued a strong buy rating on the company.

A number of research firms have recently issued reports on HLN. Zacks Research raised Haleon from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 19th. Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a research note on Tuesday, June 30th. Jefferies Financial Group restated a “buy” rating on shares of Haleon in a research note on Monday, August 24th. Rothschild & Co Redburn downgraded Haleon from a “strong-buy” rating to a “hold” rating in a report on Tuesday, June 16th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Haleon in a research report on Thursday, August 6th.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of HLN. Norges Bank acquired a new stake in Haleon during the 4th quarter worth approximately $163,529,000. Natixis Advisors LLC increased its position in Haleon by 429.8% during the fourth quarter. Natixis Advisors LLC now owns 10,003,941 shares of the company’s stock worth $101,140,000 after acquiring an additional 8,115,633 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in Haleon by 4,315.4% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 8,027,189 shares of the company’s stock worth $81,155,000 after purchasing an additional 7,845,391 shares in the last quarter. Bank of Montreal Can raised its stake in Haleon by 454.1% in the 4th quarter. Bank of Montreal Can now owns 8,500,496 shares of the company’s stock worth $85,940,000 after purchasing an additional 6,966,416 shares in the last quarter. Finally, Bank of America Corp DE boosted its holdings in Haleon by 116.7% in the 2nd quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock valued at $128,423,000 after purchasing an additional 6,669,923 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Trading Down 2.7%

Haleon stock opened at $9.59 on Thursday. The stock has a 50-day simple moving average of $9.88 and a 200 day simple moving average of $9.76. The stock has a market capitalization of $42.18 billion, a P/E ratio of 24.59, a PEG ratio of 2.14 and a beta of 0.12. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.52 and a current ratio of 0.69. Haleon has a 52 week low of $8.65 and a 52 week high of $11.28.

Haleon Cuts Dividend

The business also recently announced a dividend, which will be paid on Thursday, September 17th. Investors of record on Friday, August 14th will be issued a dividend of $0.0642 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a dividend yield of 132.0%. Haleon’s payout ratio is presently 30.77%.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over?the?counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self?care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.